Tumor Ablation Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024

Transparency Market Research presents this most up-to-date research on “Tumor Ablation Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024”

Tumor ablation is a treatment that destroys cancerous tumors without removing them. This is done using a probe that utilizes thermal energy to heat or cool tumorigenic tissue to cytotoxic levels. Techniques such as computed tomography (CT), ultrasound (US), and magnetic resonance imaging (MRI) are used to guide and position the needle probe into the tumor. Tumor ablative techniques are used in patients having few tumors which are small in size. Ablation is best used for tumors no larger than an inch. For slightly larger tumors, ablation could be used along with embolization. Moreover, surgery for tumor removal is not a feasible treatment option for certain patients often due to poor health or reduced immunity, or reduced organ function. For such cases, tumor ablation is the preferred form of treatment prescribed. Tumor ablation treatment is also highly useful in patients who are awaiting liver transplant.

Rise in cancer incidence coupled with growing preference for minimally invasive treatment options is anticipated to drive the tumor ablation market during the forecast period. However, the size of tumor treatable with this technique remains a challenge. Utilization of combination therapies to ameliorate this challenge shall further propel the market during the forecast period. Technological advancements pertaining to ablation devices is also likely to boost growth of the tumor ablation devices market. High cost of certain tumor ablation techniques such as cryoablation is likely to restrain the market during the forecast period.

The tumor ablation market has been segmented based on type of modality, application, end-user, and region. In terms of type of modality, the market has been segmented into radiofrequency ablation, laser ablation, microwave ablation, and cryoablation. Radiofrequency ablation (RFA) is the percutaneous ablative modality most commonly used for tumor ablation in developed regions of the world. Hence, the radiofrequency ablation segment is anticipated to capture a significant share of the tumor ablation market during the forecast period. Cryoablation, although expensive, is a relatively painless procedure, which enables treatment of fragile patients who are not in a position to tolerate anesthesia. Based on application, the market has been segmented into liver cancer, lung cancer, breast cancer, prostate cancer, bone cancer, kidney cancer, and other cancers. The liver cancer segment is anticipated to account for significant share of the tumor ablation market in terms of revenue owing to its preference as a mode of treatment for liver cancer patients.

Browse Global Strategic Business Report:

http://www.transparencymarketresearch.com/tumor-ablation-market.html

In terms of end-user, the market has been divided into hospitals, cancer specialty clinics, and ambulatory surgical centers. The patients going in for tumor ablation treatment typically do not require hospital stay. Hence, the ambulatory surgical centers and cancer specialty clinics segments are anticipated to witness higher growth during the forecast period.

Based on region, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to Cancer Research UK, the incidence rate of liver cancer is projected to rise by 38% in the U.K. between 2014 and 2035. Moreover, through the last decade, liver cancer incidence rate has increased by more than half (53%) in the U.K. Hence, the tumor ablation market is anticipated to witness robust growth in the U.K. during the forecast period. In the U.S. too, liver cancer incidence has more than tripled since 1980. However, cancer incidence is higher in Asia Pacific and preference for minimally invasive surgeries is rising in the region. Therefore, the market in Asia Pacific is likely to expand at a high CAGR during the forecast period.

Major players operating in the market include Medtronic, Merit Medical Systems, Inc., AngioDynamics, Inc., AtriCure, Inc., BVM Medical Limited, St. Jude Medical, Inc., DFINE, Inc., Boston Scientific Corporation, Perseon Corporation, and NeuWave Medical, Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments

  • Market trends and dynamics

  • Supply and demand

  • Market size

  • Current trends/opportunities/challenges

  • Competitive landscape

  • Technological breakthroughs

  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)

  • Latin America (Mexico, Brazil, Peru, Chile, and others)

  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)

  • Eastern Europe (Poland and Russia)

  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)

  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market

  • Important changes in market dynamics

  • Market segmentation up to the second or third level

  • Historical, current, and projected size of the market from the standpoint of both value and volume

  • Reporting and evaluation of recent industry developments

  • Market shares and strategies of key players

  • Emerging niche segments and regional markets

  • An objective assessment of the trajectory of the market

  • Recommendations to companies for strengthening their foothold in the market

 Download Exclusive Brochure of This Report :

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18656

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: www.transparencymarketresearch.com

Designed by CyFocus.com
Powered by CyFocus.net
%d bloggers like this: